CIK 0001055726
- Non-accelerated filer
- Smaller reporting company
INOVIO PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- INO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 330969592
- Phone
- +1 858-410-3134
- Business address
- 660 W. GERMANTOWN PIKE, SUITE 110, PLYMOUTH MEETING, PA, 19462
- Former names
- INOVIO BIOMEDICAL CORP, GENETRONICS BIOMEDICAL CORP, GENETRONICS BIOMEDICAL LTD
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 19,000 shares (option exercise)
- 4 Option exercise Director acquired 31,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 28,704 shares (to pay taxes)
- 4 Open-market sale Director sold 5,833 shares at $1.15 ($6,708)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 20,658 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 25,980 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 31,410 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 42,273 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 27,937 shares (to pay taxes)
- 4 Shares withheld for taxes CFO gave up 41,123 shares (to pay taxes)
- 4 Open-market sale Director sold 11,668 shares at $1.28 ($14,935)
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 4,273 shares (option exercise)
- 4 Open-market sale Director sold 11,875 shares at $2.66 ($31,588)
- 4 Open-market sale Director sold 2,000 shares at $2.25 ($4,500)
Page 5 of 30 · 592 filings